Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F29H5Xdo_vdH1aPjzaKkSeBOgLhU.uncropped.jpg&w=3840&q=75)
Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayChange DetectedThe website has updated the 'Last Update Posted' information, removing the 'Estimated' qualifier.SummaryDifference0.0%
- Check2 days agoChange DetectedNew sites added in Irvine, California, and Milan, Italy, with updates on recruitment status, while several locations in Italy and Spain have been removed from the list.SummaryDifference5%
- Check4 days agoNo Change Detected
- Check5 days agoChange DetectedThe study has expanded to 163 locations and has updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.2%
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.0%
- Check24 days agoChange DetectedThe value of Revision has recently changed from v2.9.5 to v2.9.6. This change likely includes updates or modifications to the study details or protocol.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the web page content.SummaryDifference0.0%
Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.